Published in Prostaglandins on November 25, 1974
The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest (1976) 1.07
Acute renal failure caused by nephrotoxins. Environ Health Perspect (1976) 0.75
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc (2000) 4.45
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Flow-induced release of endothelium-derived relaxing factor. Am J Physiol (1986) 3.51
Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child (1991) 3.29
Does television viewing increase obesity and reduce physical activity? Cross-sectional and longitudinal analyses among adolescent girls. Pediatrics (1993) 3.04
Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr (1992) 2.93
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Weight concerns influence the development of eating disorders: a 4-year prospective study. J Consult Clin Psychol (1996) 2.76
Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob Agents Chemother (1996) 2.72
Pursuit of thinness and onset of eating disorder symptoms in a community sample of adolescent girls: a three-year prospective analysis. Int J Eat Disord (1994) 2.49
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Educational video game for juvenile diabetes: results of a controlled trial. Med Inform (Lond) (1997) 2.12
Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc Natl Acad Sci U S A (1997) 2.12
Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc (1990) 2.02
Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol (2001) 1.99
Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol (1999) 1.96
The RAD2 domain of human exonuclease 1 exhibits 5' to 3' exonuclease and flap structure-specific endonuclease activities. J Biol Chem (1999) 1.91
CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J Clin Invest (1998) 1.87
Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science (1999) 1.86
Semi-automated entry of clinical temporal-abstraction knowledge. J Am Med Inform Assoc (1999) 1.81
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Ethnicity and body dissatisfaction: are Hispanic and Asian girls at increased risk for eating disorders? J Adolesc Health (1996) 1.78
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
3'-phosphodiesterase activity of human apurinic/apyrimidinic endonuclease at DNA double-strand break ends. Nucleic Acids Res (1997) 1.72
Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int (1988) 1.72
Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N Engl J Med (1985) 1.70
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
Patulin production in apples decayed by Penicillium expansum. Appl Microbiol (1973) 1.64
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Protonmotive force as the source of energy for adenosine 5'-triphosphate synthesis in Escherichia coli. J Bacteriol (1976) 1.62
Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell (1998) 1.61
Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab (1982) 1.59
The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int (2001) 1.56
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr (1984) 1.55
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55
Elements in abasic site recognition by the major human and Escherichia coli apurinic/apyrimidinic endonucleases. Nucleic Acids Res (1998) 1.52
Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr (1995) 1.52
Vascular expression of polycystin. J Am Soc Nephrol (1997) 1.51
Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO). Proc Natl Acad Sci U S A (2000) 1.51
Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism. J Mol Biol (2001) 1.51
Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res (2000) 1.50
Patients' perspectives of a physician-delivered smoking cessation intervention. Am J Prev Med (1991) 1.45
Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1993) 1.45
Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int (2007) 1.44
Increased oxidative stress in experimental renovascular hypertension. Hypertension (2001) 1.44
Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci (2009) 1.44
Three-dimensional microcomputed tomography of renal vasculature in rats. Hypertension (1998) 1.43
Knowledge reuse: temporal-abstraction mechanisms for the assessment of children's growth. Proc Annu Symp Comput Appl Med Care (1993) 1.40
Fungus infection in steroid-treated systemic lupus erythematosus. JAMA (1968) 1.39
Validity of measurements of calcium absorption. Pediatr Nephrol (1995) 1.39
A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int (2007) 1.38
Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol (1998) 1.37
The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis (1988) 1.36
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med (1994) 1.36
Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology (1995) 1.36
Mycotoxins produced by Aspergillus fumigatus species isolated from molded silage. J Agric Food Chem (1977) 1.34
Mapping the protein-DNA interface and the metal-binding site of the major human apurinic/apyrimidinic endonuclease. J Mol Biol (2000) 1.33
Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2000) 1.32
The progression of vesicoureteral reflux nephropathy. Ann Intern Med (1980) 1.31
Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol (1998) 1.30
First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr (2001) 1.29
Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat Biotechnol (2000) 1.29
Normal renal function: CIN and CPAH in healthy donors before and after nephrectomy. Mayo Clin Proc (1976) 1.28
Inhibition of growth of Escherichia coli by lactose and other galactosides. Biochim Biophys Acta (1981) 1.27
Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol (1988) 1.27
Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) (1995) 1.26
Effects of prostaglandins E1, E2, A1, and F1-alpha on isolated vascular smooth muscle. Am J Physiol (1967) 1.26
Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol (1991) 1.26
Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr (1995) 1.26
Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1994) 1.25
Psychiatric risk associated with early puberty in adolescent girls. J Am Acad Child Adolesc Psychiatry (1997) 1.25
Clinical features and management of cystinuria. Mayo Clin Proc (1977) 1.25
Second human protein with homology to the Escherichia coli abasic endonuclease exonuclease III. Environ Mol Mutagen (2000) 1.24
Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet (2000) 1.24
High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension (1994) 1.22
Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol (1992) 1.22
Prospective study of risk factors for the initiation of cigarette smoking. J Consult Clin Psychol (1997) 1.21
Extraction, cleanup, and quantitative determination of aflatoxins in corn. J Assoc Off Anal Chem (1980) 1.20
Hydrochlorothiazide effects on serum calcim and immunoreactive parathyroid hormone concentrations. Studies in normal subjects. Ann Intern Med (1972) 1.18
Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure. Ann Surg (1990) 1.18
Assessment and treatment of problem behavior maintained by escape from attention and access to tangible items. J Appl Behav Anal (2001) 1.18
Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int (1998) 1.17
Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension (2001) 1.17
Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Physicians (1996) 1.17
Renal involvement in relapsing polychondritis. Medicine (Baltimore) (1987) 1.16
Influence of modified atmosphere storage on aflatoxin production in high moisture corn. Appl Microbiol (1975) 1.16
Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int (1987) 1.15
Insect walking. Annu Rev Entomol (1966) 1.14
The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol (1983) 1.14
Computed tomography-derived intrarenal blood flow in renovascular and essential hypertension. Kidney Int (1996) 1.13
Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol (1997) 1.13
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int (2001) 1.13
New insights into the structure of abasic DNA from molecular dynamics simulations. Nucleic Acids Res (2000) 1.11
Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab (1983) 1.11
An attempt to modify unhealthful eating attitudes and weight regulation practices of young adolescent girls. Int J Eat Disord (1993) 1.11
Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1987) 1.11
Fibromuscular disease of the renal arteries. Med Clin North Am (1977) 1.10